2006 History Safety 
Cannabis Law Report
JUNE 2, 2022
THC metabolism (adapted from Musshoff and Madea, 2006). Durations for urine detection primarily vary with dose consumed and use history (i.e., use history, dose, elapsed time since use, etc.) Washington, DC: National Highway Traffic Safety Administration. The rapid metabolism of the psychoactive compounds (i.e.,
Cannabis Law Report
OCTOBER 14, 2021
In 2006 Tiffiny earned her J.D. in history. DCC regulations were established to ensure product safety and public protection. As the cannabis industry continues to expand and legalization on the federal level is imminent, regulations are likely to become even more restrictive in the interest of public safety.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
OCTOBER 1, 2020
This post examines the history of religious exemptions to the CSA. According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. In 2006, the U.S.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It also has an extensive and diverse history of medicinal use. 2018 ; Frankhauser 2008 ).
Cannabis Law Report
JULY 20, 2021
Salama was Assistant Branch Chief of the California Department of Public Health’s Manufactured Cannabis Safety Branch. Hillsman earned a Doctor of Philosophy degree in history and a Master of Public Affairs degree from Princeton University. Chief Deputy Director – Rasha Salama. Legal Affairs Division – Tamara Colson.
Cannabis Law Report
SEPTEMBER 23, 2019
Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.
Cannabis Law Report
APRIL 8, 2022
To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,
Expert insights. Personalized for you.
52 
Let's personalize your content